Feature

Mental Health Problems in Adolescents With HIV: Overview & Expert Interview

Adolescents infected with HIV have a greater risk for psychiatric hospitalizations compared with those not infected with HIV.

Dolutegravir Use During Pregnancy: What Are the Risks?

Early evidence of a heightened risk for birth defects with dolutegravir is concerning but remains to be fully established.

Focus on HIV-2 Infection: A Clinician Roundtable

Clinicians should be aware of the possibility of HIV-2 infection in their patients coming from endemic areas, especially West Africa.

What Is the Role of Palliative Care in the Current HIV Treatment Era?

Numerous barriers to palliative care in patients living with HIV have been identified.

Fear-Based Public Health Campaigns for HIV/AIDS Prevention: Efficacy and Ethics

Is fear the best method for educating the public about the risks of contracting HIV, or does it further stigmatize an already underserved population?

Improving the Care of Aging Adults Living With HIV

Two HIV experts discuss their ongoing research involving HIV in aging adults and provide insights on how some major health concerns can be addressed to ...

Mothers Infected With HIV: How to Advise Mothers Who Wish to Breastfeed

Some advocates say that women with undetectable viral loads should be able to breastfeed after thorough consultation with their clinicians.

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

A higher prevalence of traditional cardiovascular risk factors may be partially responsible for the increased incidence of cardiovascular disease in people living with HIV.

News Articles

Improved Care Needed for People With HIV in Prison and After Release

Improved Care Needed for People With HIV in Prison and After Release

Dedicated resources are needed to optimize HIV care for people living with HIV while they are in prison and link them to care following release.

Cardiovascular Disease Risk in PLWHIV Alters Brain Glucose Metabolism

Cardiovascular Disease Risk in PLWHIV Alters Brain Glucose Metabolism

PLWHIV who have received treatment had lower whole-brain standardized uptake values compared to healthy controls with risk for CVD as the best predictor.

Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Ages

Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Ages

Dosing recommendations for lopinavir/ritonavir include larger doses for infants; this may still result in low drug concentrations for infants younger than 6 months of age receiving the liquid formulation.

Labeling for Two HIV Drugs Updated With Safety, PK Data for Pregnant Patients

Labeling for Two HIV Drugs Updated With Safety, PK Data for Pregnant Patients

The "8.1 Pregnancy" and "12.3 Pharmacokinetics" sections have been updated with data showing no increase in the risk of overall major birth defects with 1st trimester exposure for rilpivirine.

Depression and Alcohol Misuse Lower Odds of Achieving Viral Suppression in HIV

Depression and Alcohol Misuse Lower Odds of Achieving Viral Suppression in HIV

Symptoms of depression and heavy alcohol use interact to lower the chances of achieving virologic suppression in people with HIV infection.